Actinogen Medical Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
20.00
-
-
-
-
Cost of Goods Sold (COGS) incl. D&A
13.60
221.40
365.30
360.60
356.00
Gross Income
6.40
221.40
365.30
360.60
356.00
SG&A Expense
584.60
5,356.60
7,214.90
4,236.70
9,206.30
EBIT
578.20
5,578.00
7,580.30
4,597.30
9,562.30
Unusual Expense
22.50
1.50
-
-
-
Non Operating Income/Expense
146.20
98.60
93.90
109.70
135.00
Pretax Income
440.20
5,431.00
7,382.20
4,450.10
9,388.60
Income Tax
-
-
3,748.50
1,259.70
3,158.00
Consolidated Net Income
440.20
5,431.00
3,633.80
3,190.30
6,230.60
Net Income
440.20
5,431.00
3,633.80
3,190.30
6,230.60
Net Income After Extraordinaries
440.20
5,431.00
3,633.80
3,190.30
6,230.60
Net Income Available to Common
440.20
5,431.00
3,633.80
3,190.30
6,230.60
EPS (Basic)
0.00
0.01
0.01
0.01
0.01
Basic Shares Outstanding
152,632.50
412,406.90
606,240.40
609,010.00
705,094.10
EPS (Diluted)
0.00
0.01
0.01
0.01
0.01
Diluted Shares Outstanding
152,632.50
412,406.90
606,240.40
609,010.00
705,094.10
EBITDA
564.60
5,356.60
7,214.90
4,236.70
9,206.30
Non-Operating Interest Income
14.30
49.90
104.20
37.50
38.70
About Actinogen Medical
View Profile
